| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 284,203 | 359,670 | 346,987 | | Cost of Revenue | 233,892 | 301,624 | 287,768 | | | Gross Profit | 50,311 | 58,046 | 59,219 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 50,087 | 58,347 | 58,847 | | Non Recurring | 9,160 | 12,153 | (378) | | Others | 1,027 | 1,065 | 1,053 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,963) | (13,519) | (303) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 121 | 297 | 20 | | Earnings Before Interest And Taxes | (9,842) | (13,222) | (283) | | Interest Expense | 156 | 384 | 736 | | Income Before Tax | (9,998) | (13,606) | (1,019) | | Income Tax Expense | 136 | 2,606 | 41 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,134) | (16,212) | (1,060) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,134) | (16,212) | (1,060) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,134) | ($16,212) | ($1,060) |
|
1.48% Nasdaq 0.00%
Income Statement
